Divergent differentiation in neuroendocrine lung tumors.
The classification of neuroendocrine (NE) lung tumors has been revised in the 1999 World Health Organization (WHO) classification of lung tumors, allowing sharp morphological definition of typical versus atypical carcinoids, and atypical carcinoids versus large cell neuroendocrine carcinoma (LCNEC), a newly described class of high-grade NE lung tumors which differs from small-cell lung cancer by a large-cell phenotype. Divergent differentiation accounts for the high frequency of glandular differentiation with mucin production, and ultrastructural features in carcinoids and LCNEC, and low frequency of squamous differentiation in both LCNEC and SCLC. Specific NE markers (chromogranin, synaptophysin, neural cell adhesion molecule) and epithelial markers consistently negative in neuroendocrine components (cytokeratins 1, 5, 10, 14; epidermal growth factor (EGF)-receptor, human leukocyte antigen beta 2 (HLA-beta2) microglobuline) help to recognize divergent differentiation in NE tumors. At morphological level, divergent differentiation in NE tumors is recognized in WHO classification as variants: combined SCLC and combined LCNEC. The derivation of all lung tumors from a common endodermal stem cell and adoption of amine precursor uptake and decarboxylation properties by this endodermal stem cell explains divergent differentiation in NE lung tumors and the occurrence of NE subsets in NSCLC.
Brambilla
E
E
Laboratoire de Pathologie Cellulaire, Hôpital Albert Michallon, Grenoble, France.
Lantuejoul
S
S
Sturm
N
N
D014408:Biomarkers, Tumor / Q000032:analysis; D002276:Carcinoid Tumor / Q000737:chemistry / Q000145:classification / Q000175:diagnosis* / Q000556:secondary; D018278:Carcinoma, Neuroendocrine / Q000737:chemistry / Q000145:classification / Q000175:diagnosis* / Q000556:secondary; D018288:Carcinoma, Small Cell / Q000737:chemistry / Q000145:classification / Q000175:diagnosis* / Q000556:secondary; D002454:Cell Differentiation; D003937:Diagnosis, Differential; D006801:Humans; D006965:Hyperplasia; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000737:chemistry / Q000145:classification / Q000175:diagnosis*; D009363:Neoplasm Proteins / Q000032:analysis; D009490:Neurosecretory Systems / Q000473:pathology; D014944:World Health Organization
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins